Produktname:5-Bromo-4-chloro-6-cyclopropylpyrimidine

IUPAC Name:5-bromo-4-chloro-6-cyclopropylpyrimidine

CAS:27192-21-8
Molekulare Formel:C7H6BrClN2
Reinheit:95%+
Katalognummer:CM1051304
Molekulargewicht:233.49

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM1051304-100mg in stock œƅ
CM1051304-250mg in stock ƅȋƅ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:27192-21-8
Molekulare Formel:C7H6BrClN2
Schmelzpunkt:-
SMILES-Code:ClC1=C(Br)C(=NC=N1)C1CC1
Dichte:
Katalognummer:CM1051304
Molekulargewicht:233.49
Siedepunkt:
Mdl-Nr.:MFCD11047047
Lagerung:

Category Infos

Cyclopropanes
Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.

Column Infos

TNG348
Dose escalation is ongoing in the TNG348, a novel inhibitor of USP1 (ubiquitin-specific protease 1), phase 1/2 clinical trial evaluating the safety, pharmacokinetics, pharmacodynamics and efficacy of TNG348 as a single agent and in combination with olaparib, a PARP inhibitor, in patients with BRCA1/2 mutant and other HRD+ (homologous recombination deficient) cancers. The first patient dosed was announced in January 2024.Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Related Products